59 studies found for:    hypercoagulation OR thrombophilia OR blood clotting | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Recruiting Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
Conditions: High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS;   Drug: Hydroxyurea;   Drug: Aspirin
22 Recruiting Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome
Condition: Acute Deep Vein Thrombosis
Interventions: Other: Exercise;   Other: Control
23 Unknown  Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection
Conditions: Thrombocytopenia;   Hepatitis C;   HIV Infections
Intervention: Drug: Anti-D
24 Recruiting Platelet Activity in Vascular Surgery and Cardiovascular Events
Conditions: Cardiovascular Disease;   Peripheral Artery Disease;   Critical Limb Ischemia
Intervention:
25 Recruiting Study of Procoagulation Markers in Stroke Patients
Conditions: Stroke;   Hyperglycemia;   Procoagulation Markers
Intervention: Other: Glycemic Control
26 Unknown  Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome;   Sleep Disorder
Interventions: Drug: Eszopiclone;   Other: Placebo
27 Recruiting Epigenetic Effect Modifications With Ozone Exposure on Healthy Volunteers
Condition: Exposure to Environmental Pollution, Non-occupational
Interventions: Other: Clean air;   Other: Ozone
28 Recruiting Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal Cholesterol
Condition: Healthy Volunteers
Intervention:
29 Recruiting A Phase I Trial of a Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: NY-ESO-1 157-165 (165V);   Drug: Nivolumab;   Biological: gp100:280-288 (288V);   Drug: Montanide ISA 51 vegetable grade (VG);   Drug: Ipilimumab;   Procedure: Apheresis Procedure
30 Recruiting Pre-Hospital Use of Plasma for Traumatic Hemorrhage
Condition: Shock, Hemorrhagic
Interventions: Biological: Plasma;   Drug: Normal saline
31 Recruiting Evaluation of the Safety and Immunogenicity of Autologous Thrombosomes® in Healthy Human Subjects; A Microdose Escalation Study (Cohorts 1 - 4) and Repeat Microdose Immunogenicity Study (Cohort 5)
Condition: Healthy
Interventions: Biological: Thrombosomes;   Biological: Placebo
32 Recruiting Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
Conditions: Blood Component Removal;   Human Immunodeficiency Virus
Intervention:
33 Recruiting Whole Blood and Blood Component Collection for Research
Conditions: Blood Donors;   Research Subjects;   Apheresis
Intervention:
34 Not yet recruiting Cancer Associated Thrombosis and Isoquercetin (CAT IQ)
Conditions: Thromboembolism of Vein VTE in Colorectal Cancer;   Thromboembolism of Vein in Pancreatic Cancer;   Thromboembolism of Vein in Non-small Cell Lung Cancer
Intervention: Drug: Isoquercetin
35 Recruiting Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
Condition: Thromboembolism
Interventions: Genetic: Pharmacogenetic;   Drug: Target INR 1.8
36 Recruiting Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery
Condition: HIV-1 Infection
Intervention: Drug: Isotretinoin
37 Recruiting Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
Condition: Human Immunodeficiency Virus
Intervention:
38 Recruiting Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion
Condition: Kidney Transplantation
Intervention: Biological: Kidney and hematopoietic stem cell transplant/novel platform technology
39 Recruiting Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Conditions: Renal Tumor Histology;   Cutaneous Leiomyomatosis;   Kidney Cancer
Intervention:
40 Recruiting Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
Conditions: Urethral Neoplasms;   Neoplasms, Urethral;   Ureter Cancer;   Cancer of the Urethra;   Urethral Cancer
Interventions: Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Lenalidomide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-59) Show next page of results    Last Page
Indicates status has not been verified in more than two years